CSBR

Conviction 20HealthcareScan · Mon, Aug 10, 2026

Bullish marubozu

CSBR$5.11-1.54%

ResistanceSupportVol 14

Vol MA14 33.81K

May 11May 28Jun 16Jul 6Jul 23Aug 10

CHAMPIONS ONCOLOGY, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.championsoncology.com ↗

Price5.11

Change-1.54%

Gap-1.64%

Rel volume32.16×

Avg volume26.73K

Avg $ vol141.56K

SMA 205.68

SMA 505.91

SMA 2006.22

Price vs 50-13.52%

Price vs 200-17.84%

MA stackbearish

50/200 cross—

Supertrenddown · 6.02

RSI (14)36

MACD hist-0.06

MACD crossbear · 9d

Stoch %K / %D7 / 8

ADX (14)23

+DI / −DI14 / 27

RSI divergence—

MACD divergence—

ATR %+6.20%

ADR %4.88%

52w high8.30

52w low0.0000

From 52w high-38.43%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width25.41%

%B0.11

Donchian pos7.43%

Donchian high6.48

Donchian low5.00

AVWAP (52w high)6.41

vs AVWAP high-20.31%

AVWAP (52w low)5.75

vs AVWAP low-11.11%

OBV trendDown

Chaikin MF (20)0.51

Today vs 20d32.16×

Avg vol (14d)33.81K

Avg vol (20d)26.73K

Avg $ vol (20d)141.56K

Market cap71M

RS 3m (vs SPY)-19.05%

RS 6m (vs SPY)-34.63%

RS line new highNo

Trend template0/8

Technical rank12.8

1 week-11.28%

1 month-12.20%

3 months-15.12%

6 months-21.98%

1 year-16.37%

YTD-23.27%

P/E-60.42

P/B18.02

P/S1.19

P/FCF-14.10

EPS-0.0800

Div yield—

ROE-29.83%

ROA-4.35%

Debt/Eq—

Current0.96

EV/EBITDA245.65

Gross margin—

Net margin-1.98%

Rev growth4.36%

EPS growth-124.99%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value63.87M

Revenue16.56M

Net income-279K

Gross profit—

Free cash flow-5.04M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out13.89M

Employees306

ListedMon, Oct 31, 1994

Free float5.05M

Float %36.4%

Short interest75.57K

Days to cover7.8d

Short volume20.3%

Squeeze score43 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank12.8 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish marubozu

News sentiment—

Financials as of Sat, Jan 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CSBR

All disclosures →

No recent disclosed trades by Congress in CSBR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CSBR

No recent insider (Form 4) filings in CSBR. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in CSBR · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.